NEJM Publishes CHC/GHC's CAMELIA Study:
Early HIV Treatment in Patients Co-infected with TB Saves a Significant Number of Lives
In an article published in the October 20 issue of the New England Journal of Medicine, the results of the Cambodian Early versus Late Introduction of Antiretrovirals (CAMELIA) study conducted by CHC/GHC and colleagues in Cambodia show that early HIV treatment increases survival 33 percent in patients co-infected with TB.
CHC/GHC Shows New and Promising Analytic Tools Accurately Diagnose TB
within Two Hours, A Potential Game Changer for TB Control
New and promising analytic tools accurately diagnose TB within two hours, a potential game changer for TB control.
CHC/GHC’s Commitment to Care
We deliver free TB and AIDS care to some of the poorest people on earth, because it is unacceptable that people are dying every day from treatable diseases. We strive to provide access to care in war-torn and post-conflict nations, to help restore health and peace.
Ameliorating Malnutrition and Poverty
We provide food and microfinance projects to strike at the root causes of TB and AIDS.
Partnering for Successful and Sustainable Programs
We enlist families, communities, National Health Systems and international agencies to create effective and enduring solutions.
Scaling up Success
We build capacity and work in partnership to scale up interventions to impact health care delivery at the national and international levels.
A Critical Role for Clinical and Basic Discovery
We nest research and basic discovery in our clinical care networks to find more effective and innovative approaches to treat TB and AIDS, while improving care right now.
Advocating for Access to TB and AIDS Drugs for All
We make the case for access to medicines for TB/AIDS for all who need them and for better care and more research worldwide by exposing the tragedy of TB and AIDS through testimonies, lectures, publications and exhibits.
We Measure Success in Lives Saved, in Health Restored
At the Global Health Committee, we combine medical care and outreach, basic and clinical scientific research, and advocacy to combat tuberculosis, HIV/AIDS and poverty in some of the poorest countries in the world. With our unique blend of delivery and discovery, we respond to health emergencies today, while laying the groundwork for tomorrow’s new treatments.
CHC Leads International Trial that Shows Better Survival with Rapid HIV Treatment in Patients Co-infected with TB
GHC's "South-to-South" Approach Delivers First Treatment Program for Drug-Resistant Tuberculosis
CAMELIA Trial Reaches Full Enrollment
The Faces of Success in the Battle Against MDR-TB Ethiopia
Sullivan Pediatric Center of Excellence Opens in Phnom Penh, Cambodia
CHC Leads Multi-drug Resistant TB Fight in Cambodia